IP Library Granted Patent US 7,361,368
Granted Patent B2
US 7,361,368 · App. 10/187,007 · Granted Apr 22, 2008

Device and method for combining a treatment agent and a gel

Assignee: Advanced Cardiovascular Systems, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,361,368
App. No.
10/187,007
Granted
Apr 22, 2008
Kind
B2
Abstract

A method including introducing a treatment agent at a treatment site within a mammalian host; and introducing a bioerodable gel material at the treatment site. An apparatus including a first annular member having a first lumen disposed about a length of the first annular member and a first entry port at a proximal end of the first annular member, and a second annular member coupled to the first annular member having a second lumen disposed about a length of the second annular member and a second entry port at a proximal end of the second annular member, wherein the first annular member and the second annular member are positioned to allow a combining of treatment agents introduced through each annular member at the treatment site.

Claims (33)

1. A method comprising:

introducing a first material comprising a treatment agent at a treatment site within a mammalian host; and

introducing a second material, the second material comprising a property of a bioerodable gel at the treatment site,

wherein the treatment site comprises a periadventitial site or a site radially outward of a periadventitial site and the treatment site is accessed through a blood vessel.

2. The method of claim 1 , wherein the first material and the second material are introduced separately as a combination.

3. The method of claim 1 , wherein the second material is a product of a combination of a first component and a second component and one of the first component and the second component comprises the first material.

4. The method of claim 3 , wherein introducing the second material comprises:

introducing a delivery device having a first delivery port and a second separate delivery port, the first delivery port and the second delivery port arranged in one of a co-linear and a co-axial arrangement; and

introducing the first component to the treatment site through the first delivery port; and

introducing the second component to the treatment site through the second delivery port.

5. The method of claim 1 , wherein introducing the first material comprises:

advancing a delivery device a distance into a wall of the blood vessel to the treatment site; and

after advancing the delivery device, introducing the first material through the delivery device.

6. The method of claim 1 , wherein the treatment site is a periadventitial site.

7. The method of claim 1 , wherein introducing the second material follows the introduction of the first material.

8. The method of claim 1 , wherein introducing the second material precedes the introduction of the first material.

9. The method of claim 4 , wherein the treatment site is selected from the group consisting of a thoroscopic surgery site, an orthoscopic surgery site, and a laparoscopic surgery site.

10. A method comprising:

positioning a delivery device at a location in a blood vessel;

advancing the delivery device a distance into a wall of the blood vessel to a treatment site; and

after advancing the delivery device, introducing a first material comprising a treatment agent and a second material comprising a property of a bioerodable gel at the treatment site.

11. The method of claim 10 , wherein the first material and the second material are introduced as a combination.

12. The method of claim 11 , wherein the second material is a product of a combination of a first component and a second component and one of the first component and the second component comprises the first material.

13. The method of claim 12 , wherein introducing the second material comprises:

introducing a delivery device having a first delivery port and a second separate delivery port, the first delivery port and the second delivery port arranged in one of a co-linear and a co-axial arrangement; and introducing the first component to the treatment site through the first delivery port; and introducing the second component to the treatment site through the second delivery port.

14. The method of claim 13 , wherein the treatment site is associated with a blood vessel.

15. The method of claim 14 , wherein introducing the first material comprises:

advancing the delivery device a distance into a wall of the blood vessel to the treatment site; and

after advancing the delivery device, introducing the first material through the delivery device.

16. The method of claim 15 , wherein the treatment site comprises a location, with reference to a lumen of the blood vessel, beyond the medial layer of the blood vessel.

17. The method of claim 16 , wherein the treatment site comprises a periadventitial site.

18. The method of claim 10 , wherein introducing the second material follows the introduction of the first material.

19. The method of claim 10 , wherein introducing the second material precedes the introduction of the first material.

Assignments (2)
CHANGE OF NAME Recorded Jul 19, 2012
From: ADVANCED CARDIOVASCULAR SYSTEMS, INC.
To: ABBOTT CARDIOVASCULAR SYSTEMS INC.
Reel/Frame 028601/0893 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2002
From: CLAUDE, CHARLES D.; KAWULA, PAUL J.; HOSSAINY, SYED FAIYAZ AHMED; TRAN, KIMCHI
To: ADVANCED CARDIOVASCULAR SYSTEMS, INC.
Reel/Frame 013083/0145 →
Continuity (1)
Related Publication 20040002692A1 · Jan 1, 2004